.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Accenture
Cantor Fitzgerald
Boehringer Ingelheim
Fish and Richardson
Merck
Fuji
McKinsey
UBS
Baxter

Generated: December 12, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 205034

« Back to Dashboard

NDA 205034 describes VORICONAZOLE, which is a drug marketed by Amneal Pharms, Mylan Pharms Inc, Novel Labs Inc, Alvogen Inc, Sandoz Inc, Xellia Pharms Aps, Ajanta Pharma Ltd, Akorn, Appco Pharma Llc, Aurobindo Pharma Ltd, Glenmark Pharms Ltd, Prinston Inc, Teva Pharms, and Zydus Pharms Usa Inc, and is included in seventeen NDAs. It is available from twenty-seven suppliers. Additional details are available on the VORICONAZOLE profile page.

The generic ingredient in VORICONAZOLE is voriconazole. There are thirteen drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the voriconazole profile page.

Summary for 205034

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Antifungals
Formulation / Manufacturing:see details

Medical Subject Heading (MeSH) Categories for 205034

Suppliers and Packaging for NDA: 205034

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
VORICONAZOLE voriconazole FOR SUSPENSION;ORAL 205034 ANDA Amneal Pharmaceuticals LLC 65162-913 65162-913-22 75 mL in 1 BOTTLE (65162-913-22)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:FOR SUSPENSION;ORALStrength200MG/5ML
Approval Date:Apr 13, 2016TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Medtronic
Julphar
US Department of Justice
Citi
Argus Health
Queensland Health
AstraZeneca
Mallinckrodt
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot